Thoroughbred Financial Services’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $598K | Sell |
8,561
-17,332
| -67% | -$1.21M | 0.04% | 340 |
|
|
2025
Q1 | $1.9M | Buy |
25,893
+253
| +1% | +$18.6K | 0.12% | 178 |
|
|
2024
Q4 | $1.68M | Sell |
25,640
-2,539
| -9% | -$166K | 0.1% | 185 |
|
|
2024
Q3 | $2.2M | Sell |
28,179
-65
| -0.2% | -$5.06K | 0.14% | 139 |
|
|
2024
Q2 | $2.2M | Buy |
28,244
+16,695
| +145% | +$1.3M | 0.15% | 137 |
|
|
2024
Q1 | $782K | Sell |
11,549
-23,580
| -67% | -$1.6M | 0.08% | 236 |
|
|
2023
Q4 | $2.37M | Buy |
35,129
+2,211
| +7% | +$149K | 0.19% | 110 |
|
|
2023
Q3 | $2.23M | Buy |
32,918
+15,429
| +88% | +$1.04M | 0.22% | 96 |
|
|
2023
Q2 | $1.25M | Buy |
17,489
+1,240
| +8% | +$88.7K | 0.16% | 140 |
|
|
2023
Q1 | $1.13M | Buy |
16,249
+3,131
| +24% | +$217K | 0.17% | 145 |
|
|
2022
Q4 | $889K | Buy |
+13,118
| New | +$889K | 0.15% | 157 |
|